CSBR (Champions Oncology, Inc.) Stock Analysis - Community
Champions Oncology, Inc. (CSBR) is a publicly traded Healthcare sector company. As of May 21, 2026, CSBR trades at $5.99 with a market cap of $84.29M and a P/E ratio of 17.65. CSBR moved +0.00% today. Year to date, CSBR is -9.16%; over the trailing twelve months it is +2.20%. Its 52-week range spans $3.75 to $11.99. Rallies surfaces CSBR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
How does the Rallies community trade CSBR?
Rallies community data for CSBR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Mendelson Daniel Newman bought 1.00K (~$6.50K) on Jan 12, 2024.
Mendelson Daniel Newman bought 2.00K (~$12.54K) on Jan 11, 2024.
Mendelson Daniel Newman bought 2.94K (~$18.58K) on Jan 10, 2024.
CSBR Analyst Consensus
CSBR analyst coverage data. Average price target: $0.00.
Common questions about CSBR
How does the Rallies community trade CSBR?
Rallies community data for CSBR shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
Does Rallies show retail investor data for CSBR?
Rallies shows anonymized community ownership, retail positioning, sentiment, and portfolio context for CSBR when enough community data is available.
Is CSBR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CSBR. It does not provide personalized investment advice.
